Back to search

Article

Correlation of inhaled long-acting bronchodilators with cardiovascular adverse events in COPD patients: A real-world analysis of post-marketing surveillance data

2023-11-07

Abstract excerpt

<h4>Background: </h4> The question of whether inhaled long-acting bronchodilators (iLABs) increase the incidence of cardiovascular adverse events (CVAEs) remains unresolved. The present study analyzed real world data using the U.S. Food and Drug Administration Adverse Events Reporting System (FAERS) database to evaluate iLABs-related CVAEs in patients with COPD. <h4>Methods:</h4> Disproportionality analysis was us...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
38e694a3-397f-558f-b178-0a5735e03933
DOI
10.22541/au.169934442.22991218/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Correlation of inhaled long-acting bronchodilators with cardiovascular adverse events in COPD patients: A real-world analysis of post-marketing surveillance dataDOI 10.22541/au.169934442.22991218/v1
Select a neighboring publication to make it the new centre.